Sequenom (SQNM), Illumina (ILMN) Sign Equipment, Consumable Supply Agreement
Tweet
Share
E-mailGet Alerts SQNM Hot Sheet
Join SI Premium – FREE
Sequenom, Inc. (Nasdaq: SQNM), has signed a three-year supply agreement with Illumina, Inc. (Nasdaq: ILMN).
From the release: "Under the terms of the agreement, Sequenom and its subsidiaries will purchase Illumina's sequencing equipment and consumables for use in the development of a noninvasive test designed to detect an overabundance of chromosome 21 in pregnant women, a result associated with fetal Down syndrome.
Sequenom and Illumina will work collaboratively toward the submission for regulatory approval of an in vitro diagnostic product for the detection of fetal chromosomal abnormalities."
From the release: "Under the terms of the agreement, Sequenom and its subsidiaries will purchase Illumina's sequencing equipment and consumables for use in the development of a noninvasive test designed to detect an overabundance of chromosome 21 in pregnant women, a result associated with fetal Down syndrome.
Sequenom and Illumina will work collaboratively toward the submission for regulatory approval of an in vitro diagnostic product for the detection of fetal chromosomal abnormalities."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synaptics CFO resigns amid pending ON Semiconductor merger
- Albemarle names Max Hood as chief accounting officer
- Ubiquiti extends $500M stock buyback program through 2027
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
